GPCR · Structure Therapeutics Inc.
Market Cap
$3.17B
Shares
71.31M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$40.38
Open$46.84
Day$40.26–47.38
52W close$20.20–93.79
Avg vol 30d739K
Short int6.1M · 8.5% float · 10.4d
Short vol65%
Last earningsNov 13, 2024
DataFeb 2023–Sep 2026
Filing10-Q · Aug 6
Up next
filed Aug 6, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$214.84M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$1.34B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+26.2%
Year over year · more shares
Price change (1Y)
+93.6%
Trailing year
Short interest
8.5%
Latest settlement · 10.4 days to cover
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 15.7 · calm
Equity put/call 0.48
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−26%
below
Price vs 50-day avg
−20%
below
RSI (14)
27
oversold
MACD trend
Negative
52-week position
27%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−25%
trailing
6-month return
−28%
trailing
YTD return
−42%
this year
Relative strength
−42%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $51 › 200d $54 — 200d above 50d
Institutional flow
Distributing
-3% holders QoQ · +29 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
8.53% of float · ▲ +0.5% MoM · 10.4 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
194 holders — near 3-yr high, broad support
Squeeze score
55
elevated · 0–100
Fundamentals
EPS growth
−3%
Y/Y
Free cash flow
$-225.8M
Quant / Vol
risk profile
Volatility
119%
annualized · 1-yr
Max drawdown
−62%
past year
ATR
6.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−26%
Bearish
Price vs 50-day avg
−20%
Bearish
RSI (14)
27
Neutral
MACD trend
Negative
Bearish
52-week position
27%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $51 › 200d $54 — 200d above 50d
Institutional flow
Distributing
-3% holders QoQ · +29 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
8.53% of float · ▲ +0.5% MoM · 10.4 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
194 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $20
Now $40 · 27%
Range high $94
vs 200-day avg -26%
vs 50-day avg -20%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GPCR
this stock
Structure Therapeutics Inc.
|
$3.17B | -41.9% | — | — | 8.5% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.42B | +16.7% | +46.2% | 31.8 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$83.15B | +5.0% | +20.8% | 20.0 | 2.3% |
|
ARGX
Argenx SE
|
$62.63B | +19.8% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$60.54B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GPCR | -12.1% | -25.0% | -28.1% | -12.1% | -41.9% |
| SPY | -0.1% | -0.9% | +14.2% | -0.1% | +12.3% |
| vs SPY | -11.9% | -24.0% | -42.3% | -11.9% | -54.3% |
Key facts
CIK
1888886
CUSIP
86366E106
13F (30d)
135 filings
135 filers
Visit website
Investor relations